TP53 and adenocarcinoma: The other patient had stage 4 disease with ovarian metastasis (adenocarcinoma histology, PD-L1 CPS 5, TMB 6.3 mut/Mb, TP53 mutation, CCNE1 and ERBB2 amplification, and HER3 3+).